Mahamaya lifesciences Limited has withdrawn its participation from a major investor conference due to scheduling conflicts and business priorities. The company formally notified the Bombay Stock Exchange of this decision through a regulatory filing on March 9, 2026.

Conference Withdrawal Details

The pharmaceutical company was originally scheduled to participate in the Arihant Capital Bharat Connect Virtual Conference Rising Star 2026. However, the management decided to withdraw from the event citing internal scheduling constraints and ongoing business priorities that required immediate attention.

Regulatory Compliance

The withdrawal was communicated to the stock exchange in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, which mandates disclosure of material events and information. The company had previously informed the exchange about its participation plans on March 5, 2026, making the withdrawal notification necessary to maintain transparency with investors and regulatory authorities.

Management Communication

Managing Director Krishnamurthy Ganesan signed the official communication to the Bombay Stock Exchange, emphasizing that the decision was driven by internal operational requirements. The company assured that this withdrawal was purely due to scheduling conflicts rather than any fundamental business concerns.

The notification serves to keep investors and stakeholders informed about changes in the company's investor engagement activities, maintaining the transparency standards required under securities regulations.

Mahamaya lifesciences Limited has been recognized with a prestigious industry award, marking a significant achievement for the pharmaceutical company. The company received the 'Company of the Year – Medium Scale' award at the International Crop Science Conference & Exhibition (ICSCE) 2026 held in Dubai, demonstrating its excellence in the medium-scale pharmaceutical sector.

Award Recognition Details

The award was presented on January 20, 2026, as part of the PMFAI SML Awards 2026. The recognition comes from the Pesticides Manufacturers & Formulators Association of India (PMFAI), a leading industry body that acknowledges outstanding performance and contributions in the sector.

Regulatory Compliance

Mahamaya Lifesciences Limited disclosed this achievement through a formal communication to the Bombay Stock Exchange Limited on January 22, 2026. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically under Part B of Schedule III, which covers events that require disclosure based on materiality guidelines.

The company's Managing Director, Krishnamurthy Ganesan (DIN: 00270539), signed the disclosure document, ensuring compliance with regulatory requirements. The company trades on BSE with scrip code 544611.

Company Profile

Mahamaya Lifesciences Limited, formerly known as Mahamaya Lifesciences Pvt. Ltd., operates as an ISO 9001:2015 certified company. The organization is headquartered at Spaze ITech Park in Gurugram, Haryana, and maintains its corporate identity number as U24233DL2002PLC115261.

This recognition at ICSCE 2026 reflects the company's commitment to excellence in the pharmaceutical and lifesciences sector, positioning it among the leading medium-scale companies in the industry.